The Science Behind CAS 212322-56-0: A Deep Dive for Pharma Professionals
For professionals in pharmaceutical research and development, a deep understanding of chemical intermediates is fundamental to successful drug discovery and manufacturing. Ethyl 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic Acid Ester, identified by its CAS number 212322-56-0, is a compound that warrants close attention due to its critical role as a pharmaceutical intermediate. This article offers a scientific overview for those looking to buy or understand this essential molecule.
The chemical structure of Ethyl 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic Acid Ester is complex, featuring an ester group, an amino-substituted benzoyl moiety, and a pyridinylamino group linked via a propionic acid chain. Its molecular formula is C18H22N4O3, with a molecular weight of 342.39 g/mol. These parameters are crucial for chemists planning synthetic routes and analytical scientists developing quality control methods. The compound typically presents as a white to off-white powder, indicative of its intended high purity, usually around 99%.
The primary significance of CAS 212322-56-0 lies in its application as a key precursor in the synthesis of Dabigatran, a prominent oral anticoagulant. Dabigatran's efficacy as a direct thrombin inhibitor relies heavily on the precise structure and purity of its precursor molecules. Therefore, when procuring this intermediate, it is vital to ensure it is sourced from a reliable manufacturer that guarantees adherence to pharmaceutical-grade specifications. As a manufacturer based in China, we provide this assurance, offering competitive pricing for bulk quantities and detailed technical data.
Understanding the synthesis of such intermediates is also a valuable aspect for R&D scientists. While specific synthetic pathways can be proprietary, general knowledge of how this compound is produced—often involving multi-step organic reactions, such as reduction of nitro groups and esterification—highlights the complexity and precision involved. For any pharmaceutical company aiming to buy this essential building block, engaging with a supplier that can provide not just the material but also technical support and a clear understanding of its origin and quality is paramount. We are dedicated to being that partner for your pharmaceutical intermediate needs.
Perspectives & Insights
Nano Explorer 01
“Understanding the synthesis of such intermediates is also a valuable aspect for R&D scientists.”
Data Catalyst One
“While specific synthetic pathways can be proprietary, general knowledge of how this compound is produced—often involving multi-step organic reactions, such as reduction of nitro groups and esterification—highlights the complexity and precision involved.”
Chem Thinker Labs
“For any pharmaceutical company aiming to buy this essential building block, engaging with a supplier that can provide not just the material but also technical support and a clear understanding of its origin and quality is paramount.”